XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue:        
Total revenue $ 1,964 $ 5,911 $ 4,042 $ 13,145
Costs and expenses:        
Research and development 3,850 8,025 8,321 14,681
Selling, general and administrative 6,296 7,824 13,595 17,054
Total costs and expenses 15,015 20,930 30,780 43,021
Loss from operations (13,051) (15,019) (26,738) (29,876)
Other income (expense):        
Interest income 2 2 4 5
Interest expense (1,541) (1,346) (3,063) (2,996)
Change in fair value of derivative related to Term Loan 1,022 (1,675) 252 (1,675)
Change in fair value of warrant liabilities 7,192   5,888  
Other income 37 4 37 13
Other expense     (682)  
Other losses (8)   (10)  
Total other income (expense) 6,704 (3,015) 2,426 (4,653)
Net loss $ (6,347) $ (18,034) $ (24,312) $ (34,529)
Net loss per share — basic $ (0.08) $ (5.1) $ (0.51) $ (9.96)
Net loss per share — diluted $ (0.08) $ (5.1) $ (0.51) $ (9.96)
Weighted-average number of common shares used in computing net loss per share — basic 80,916,888 3,535,763 47,460,986 3,466,816
Weighted-average number of common shares used in computing net loss per share — diluted 80,916,888 3,535,763 47,460,986 3,466,816
Other comprehensive loss:        
Net loss $ (6,347) $ (18,034) $ (24,312) $ (34,529)
Net unrealized gain on marketable securities arising during the period   9   2
Net realized loss on marketable securities included in net loss   2   2
Total other comprehensive income, net of taxes   11   4
Comprehensive loss (6,347) (18,023) (24,312) (34,525)
Product [Member]        
Revenue:        
Total revenue 1,964 2,559 3,619 6,403
Costs and expenses:        
Cost of product revenue $ 4,869 5,081 8,864 11,286
Contribution [Member]        
Revenue:        
Total revenue   $ 3,352 $ 423 $ 6,742